{"version":"company-facts.v1","source":"https://secwatch.observer","generated_at":"2026-09-01T05:29:07.566810+00:00","company":{"ticker":"LMMY","cik":1939937,"company_name":"Exousia Bio, Inc."},"pagination":{"limit":100,"returned":3,"next_cursor":null},"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer","counterparties":{"ma_counterparty":[{"display_name":"Exousia Ai, Inc.","detail":"acquisition","count":1,"first_seen":"2025-11-17T23:59:59+00:00","last_seen":"2025-11-17T23:59:59+00:00","evidence_fact_ids":[26320]},{"display_name":"Zhang Shengwu","detail":"change_of_control","count":1,"first_seen":"2024-12-17T23:59:59+00:00","last_seen":"2024-12-17T23:59:59+00:00","evidence_fact_ids":[102879]}]},"facts":[{"fact_type":"ma_transaction","fact_key":"34a9d3864b95fd55150ace47281400cc13cba9f3","cik":1939937,"ticker":"LMMY","company_name":"Exousia Bio, Inc.","filed_at":"2025-11-17T23:59:59+00:00","payload":{"action":"acquisition","closing_date":"2025-11-17","consideration_text":"62,223,000 shares of Company common stock","counterparty":"Exousia Ai, Inc.","effective_date":"2025-11-17","item_codes_triggered":["2.01","5.01"]},"claim":"Exousia Bio, Inc. completed an acquisition involving Exousia Ai, Inc. for 62,223,000 shares of Company common stock (closed 2025-11-17).","evidence_excerpt":"of the issued and outstanding capital stock\nof Exousia Ai, with Exousia Ai becoming the Company’s wholly-owned subsidiary, in consideration of the Company’s issuing a\ntotal of 62,223,000 shares of Company common stock (the “Acquisition Shares” ) to the shareholders of Exousia\nAi. On November 17, 2025, the\nparties closed the Reorganization Agreement, such that","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001683168-25-008486","anchor_url":"https://secwatch.observer/filing/0001683168-25-008486#claim-34a9d3864b95fd55150ace47281400cc13cba9f3","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1939937/000168316825008486/0001683168-25-008486-index.htm"},{"fact_type":"ma_transaction","fact_key":"291a40d77e95d7ebe0dcfafa461e82b0959fdb30","cik":1939937,"ticker":"LMMY","company_name":"Exousia Bio, Inc.","filed_at":"2024-12-17T23:59:59+00:00","payload":{"action":"change_of_control","closing_date":"2024-12-06","consideration_text":"$335,910 in cash","counterparty":"Zhang Shengwu","effective_date":"2024-12-06","item_codes_triggered":["5.01"]},"claim":"Exousia Bio, Inc. underwent a change of control involving Zhang Shengwu for $335,910 in cash (closed 2024-12-06).","evidence_excerpt":"of the\noutstanding shares of the Company’s common stock and constitute voting control of the Company. The total consideration paid\nby Mr. Shengwu for the Acquired Shares was $335,910 in cash, $318,410 to Mr. Witmer and $17,500 to Mr. Townsend. In conjunction with the Change-in-Control\nAgreements, on December 6, 2024, Dwight Witmer resigned as a Director, CEO,","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001683168-24-008767","anchor_url":"https://secwatch.observer/filing/0001683168-24-008767#claim-291a40d77e95d7ebe0dcfafa461e82b0959fdb30","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1939937/000168316824008767/0001683168-24-008767-index.htm"},{"fact_type":"executive_change","fact_key":"2e630639f3","cik":1939937,"ticker":"LMMY","company_name":"Exousia Bio, Inc.","filed_at":"2023-03-17T23:59:59+00:00","payload":{"action":"appointed","action_category":"appointment","departure_tone":"not_applicable","effective_date":"2023-03-15","interim":false,"role":"Chief Operating Officer","role_category":"coo","successor_name":null,"successor_named":false},"claim":"Stephen Edward Townsend was appointed as Chief Operating Officer at Exousia Bio, Inc..","evidence_excerpt":"On March 15, 2023, the board of directors (the “Board”) of LAMY (the “Company”) appointed Mr. Stephen Edward Townsend, to the Board as Chief Operating Officer.","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0001683168-23-001567","anchor_url":"https://secwatch.observer/filing/0001683168-23-001567#claim-2e630639f3","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1939937/000168316823001567/0001683168-23-001567-index.htm"}]}